Anticancer drug restores hearing in some patients with neurofibromatosis

Anticancer drug restores hearing in some patients with neurofibromatosis

An estimated one in 25,000 people is born with NF2, a hereditary tumor syndrome in which virtually everyone progresses to deafness because of vestibular schwannomas—tumors growing on the nerves responsible for hearing. The tumors arise from the …

(Visited 1 times, 1 visits today)
9
Like
Save

Comments

Comments are disabled for this post.